UY33384A - Dronedarona para prevenir accidentes de fibrilacion auricular - Google Patents

Dronedarona para prevenir accidentes de fibrilacion auricular

Info

Publication number
UY33384A
UY33384A UY0001033384A UY33384A UY33384A UY 33384 A UY33384 A UY 33384A UY 0001033384 A UY0001033384 A UY 0001033384A UY 33384 A UY33384 A UY 33384A UY 33384 A UY33384 A UY 33384A
Authority
UY
Uruguay
Prior art keywords
dronedarona
fibrilation
headphones
prevent accidents
cardiovascular
Prior art date
Application number
UY0001033384A
Other languages
English (en)
Inventor
Gaudin Christophe
Martin Van Eickels
Original Assignee
Sanofi Adventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10305514A external-priority patent/EP2387996A1/en
Priority claimed from EP10305522A external-priority patent/EP2387997A1/en
Application filed by Sanofi Adventis filed Critical Sanofi Adventis
Publication of UY33384A publication Critical patent/UY33384A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de dronedarona para la preparación de un medicamento para la prevención de la muerte o las hospitalizaciones cardiovasculares o los sucesos cardiovasculares particularmente el ictus, el síndrome coronario agudo o la muerte cardiovascular en pacientes con fibrilación auricular permanente.
UY0001033384A 2010-05-13 2011-05-13 Dronedarona para prevenir accidentes de fibrilacion auricular UY33384A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33435010P 2010-05-13 2010-05-13
EP10305514A EP2387996A1 (en) 2010-05-17 2010-05-17 Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation
EP10305522A EP2387997A1 (en) 2010-05-18 2010-05-18 Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients who developed permanent atrial fibrillation throughout the period the dronedarone is administered
US34610210P 2010-05-19 2010-05-19

Publications (1)

Publication Number Publication Date
UY33384A true UY33384A (es) 2011-12-30

Family

ID=44260395

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033384A UY33384A (es) 2010-05-13 2011-05-13 Dronedarona para prevenir accidentes de fibrilacion auricular

Country Status (4)

Country Link
AR (1) AR081392A1 (es)
TW (1) TW201200131A (es)
UY (1) UY33384A (es)
WO (1) WO2011141888A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665444B1 (fr) 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
KR20100135909A (ko) * 2008-04-17 2010-12-27 사노피-아벤티스 심혈관성 입원 또는 사망을 예방하는데 사용하기 위한 약제의 제조에 있어서의 드로네다론의 용도
EP2133074A1 (en) * 2008-06-10 2009-12-16 Sanofi-Aventis Use of dronedarone for the preparation of a medicament intended for the prevention of permanent atrial fibrillation
EP2153830A1 (en) * 2008-08-07 2010-02-17 Sanofi-Aventis Use of dronedarone for the preparation of a medicament intended for the prevention of stroke or transient ischemic attack

Also Published As

Publication number Publication date
TW201200131A (en) 2012-01-01
AR081392A1 (es) 2012-08-29
WO2011141888A1 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
ECSP10010666A (es) Dronedarona para la prevención de la fibrilación auricular permanente
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
NI201000172A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad.
ES2620754T3 (es) Uso de 5-androstano (alquil)-3,5,6-triol en la preparación de fármacos neuroprotectores
NI201200191A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
BR112012024432A2 (pt) composição farmacêutica de dissolução rápida
MX2016008429A (es) Derivado de piranocromenil fenol, y composicion farmaceutica para tratar un sindrome metabolico o enfermedad inflamatoria.
NI201100034A (es) Uso de dronedarona para la preparación de un medicamento para la prevención de ictus o ataque isquémico transitorio.
UY32618A (es) Combinación antitumoral que comprende ave8062 y sorafenib
BR112014025416A2 (pt) AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS.
MX2016007682A (es) Composicion farmaceutica que comprende ivabradina amorfa.
CL2010001421A1 (es) Uso de dronedarona en la preparacion de medicamentos utiles para la prevencion de fibrilacion o aleteo auricular persistentes.
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”
HRP20130082A2 (hr) Farmaceutski pripravak za produljeno oslobađanje trimetazidina
AR084169A1 (es) Combinacion que comprende un derivado de la familia de las combretastatinas y cetuximab
UY33384A (es) Dronedarona para prevenir accidentes de fibrilacion auricular
CR20140526A (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis
BR112016007306A2 (pt) uso do odiparcil no tratamento da mucopolissacaridose
RU2013155770A (ru) Средство для коррекции нарушений в легочной ткани при цитостатическом воздействии
NI201200183A (es) Una combinación antitumoral que comprende ombrabulina, un derivado de taxano y un derivado de platino
UY34514A (es) ?derivados miméticos de brasinoesteroides no esteroideos, composición, métodos y usos que los comprenden?.
AR084975A1 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de la hospitalizacion cardiovascular o de la mortalidad en pacientes con fibrilacion auricular aislada
TR201009607U (tr) Parçaları birleştirmede kullanılan vidaların gizlenmesi.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200626